drugset / Trial / NCT01139047
Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the tolerability of MetroGel® 1% to Finacea® 15% in subjects with healthy skin applied according to product labeling for three weeks.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azelaic acid | Small molecule | 15 % | Topical |
| Comparator | Metronidazole | Small molecule | 1 % | Topical |